A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma. [electronic resource]
Producer: 20070503Description: 374-80 p. digitalISSN:- 1042-8194
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics
- Cisplatin -- administration & dosage
- Cytarabine -- administration & dosage
- Female
- Humans
- Isoquinolines -- administration & dosage
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Follicular -- drug therapy
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Male
- Methylprednisolone -- administration & dosage
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prospective Studies
- Remission Induction
- Salvage Therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.